Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group.
Thadani
U
U
University of Oklahoma Health Sciences Center, Oklahoma City 73194.
D000328:Adult; D000368:Aged; D017311:Amlodipine; D000787:Angina Pectoris / Q000188:drug therapy*; D002121:Calcium Channel Blockers; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005080:Exercise Test; D006801:Humans; D008875:Middle Aged; D009543:Nifedipine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010919:Placebos; D013997:Time Factors
D002121:Calcium Channel Blockers; D010919:Placebos; D017311:Amlodipine; D009543:Nifedipine